Overview

CKD-391 Pharmacokinetic Study

Status:
Completed

Trial end date:
2015-10-01

Target enrollment:

Participant gender:

Summary

A randomized, open-label, 2-way crossover study to compare the pharmacokinetics and safety CKD-391 to coadministration Atorvastatin and Ezetimibe in health volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

Chong Kun Dang Pharmaceutical

Treatments:

Ezetimibe